Answers are grounded in this paper and cite their sources.
Minireview examines how HPV uses cellular polymerases during its life cycle, implying cancer risk.
High-risk human papillomaviruses (HPVs) cause cervical, anogenital, and head and neck cancers. A key oncogenic mechanism involves viral exploitation of host DNA damage tolerance pathways to support productive replication, a process that also drives genomic instability. Despite evidence that specific cellular polymerases participate in HPV genome replication, the full complement of polymerases deployed across the viral life cycle remains poorly defined. This minireview examines the potential roles of both replicative and translesion synthesis (TLS) polymerases at distinct stages of the HPV life cycle, and new tools that can be used to assess their potential importance in driving cancer, the life cycle, and altering mutagenic potential.
No takes yet. Share an insight, caveat, or question.
Ylvisaker et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: